These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16040623)

  • 21. The trend of susceptibilities to amphotericin B and fluconazole of Candida species from 1999 to 2002 in Taiwan.
    Yang YL; Li SY; Cheng HH; Lo HJ;
    BMC Infect Dis; 2005 Nov; 5():99. PubMed ID: 16266438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples].
    Hüseyin A; Sancak B; Arikan S
    Mikrobiyol Bul; 2007 Apr; 41(2):235-44. PubMed ID: 17682710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for candidemia-related mortality at a medical center in central Taiwan.
    Cheng YR; Lin LC; Young TG; Liu CE; Chen CH; Tsay RW
    J Microbiol Immunol Infect; 2006 Apr; 39(2):155-61. PubMed ID: 16604249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
    Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Meis JF; Gould IM; Fu W; Colombo AL; Rodriguez-Noriega E;
    J Clin Microbiol; 2007 Jun; 45(6):1735-45. PubMed ID: 17442797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management.
    Chen SC; Marriott D; Playford EG; Nguyen Q; Ellis D; Meyer W; Sorrell TC; Slavin M;
    Clin Microbiol Infect; 2009 Jul; 15(7):662-9. PubMed ID: 19614718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Invasive fungal infections following liver transplantation: incidence, risk factors, survival, and impact of fluconazole-resistant Candida parapsilosis (2003-2007).
    Raghuram A; Restrepo A; Safadjou S; Cooley J; Orloff M; Hardy D; Butler S; Koval CE
    Liver Transpl; 2012 Sep; 18(9):1100-9. PubMed ID: 22577087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Invasive Candida species infection: the importance of adequate empirical antifungal therapy.
    Armstrong-James D
    J Antimicrob Chemother; 2007 Sep; 60(3):459-60. PubMed ID: 17646200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: in vitro susceptibility of 375 Candida albicans isolates and biofilm production.
    Tortorano AM; Prigitano A; Biraghi E; Viviani MA;
    J Antimicrob Chemother; 2005 Oct; 56(4):777-9. PubMed ID: 16144871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Multicenter study of fungemia due to yeasts in Argentina].
    Rodero L; Davel G; Soria M; Vivot W; Córdoba S; Canteros CE; Saporiti A;
    Rev Argent Microbiol; 2005; 37(4):189-95. PubMed ID: 16502638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
    Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Candida endophthalmitis: focus on current and future antifungal treatment options.
    Khan FA; Slain D; Khakoo RA
    Pharmacotherapy; 2007 Dec; 27(12):1711-21. PubMed ID: 18041891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population-based laboratory surveillance for tribe Proteeae isolates in a large Canadian health region.
    Laupland KB; Parkins MD; Ross T; Pitout JD
    Clin Microbiol Infect; 2007 Jul; 13(7):683-8. PubMed ID: 17403132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study.
    Manzoni P; Arisio R; Mostert M; Leonessa M; Farina D; Latino MA; Gomirato G
    Pediatrics; 2006 Jan; 117(1):e22-32. PubMed ID: 16326690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
    Charlier C; Hart E; Lefort A; Ribaud P; Dromer F; Denning DW; Lortholary O
    J Antimicrob Chemother; 2006 Mar; 57(3):384-410. PubMed ID: 16449304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital.
    Capoor MR; Nair D; Deb M; Verma PK; Srivastava L; Aggarwal P
    Jpn J Infect Dis; 2005 Dec; 58(6):344-8. PubMed ID: 16377864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation.
    Shi SH; Lu AW; Shen Y; Jia CK; Wang WL; Xie HY; Zhang M; Liang TB; Zheng SS
    Chin Med J (Engl); 2008 Apr; 121(7):625-30. PubMed ID: 18466683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations.
    Xu Y; Chen L; Li C
    J Antimicrob Chemother; 2008 Apr; 61(4):798-804. PubMed ID: 18218640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight.
    Kaufman D; Boyle R; Hazen KC; Patrie JT; Robinson M; Grossman LB
    J Pediatr; 2005 Aug; 147(2):172-9. PubMed ID: 16126045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Candida glabrata fungemia: experience in a tertiary care center.
    Malani A; Hmoud J; Chiu L; Carver PL; Bielaczyc A; Kauffman CA
    Clin Infect Dis; 2005 Oct; 41(7):975-81. PubMed ID: 16142662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consensus statement on the management of invasive candidiasis in Intensive Care Units in the Asia-Pacific Region.
    Hsueh PR; Graybill JR; Playford EG; Watcharananan SP; Oh MD; Ja'alam K; Huang S; Nangia V; Kurup A; Padiglione AA
    Int J Antimicrob Agents; 2009 Sep; 34(3):205-9. PubMed ID: 19409759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.